Transcat, Inc. (NASDAQ:TRNS) Receives $130.25 Average PT from Analysts

Transcat, Inc. (NASDAQ:TRNS - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the five brokerages that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $130.25.

A number of analysts have recently issued reports on the stock. HC Wainwright reiterated a "buy" rating and issued a $156.00 price objective on shares of Transcat in a report on Tuesday, October 29th. Craig Hallum boosted their price target on shares of Transcat from $113.00 to $125.00 and gave the stock a "buy" rating in a research report on Thursday, December 12th. Northland Securities decreased their price objective on Transcat from $130.00 to $110.00 and set a "market perform" rating for the company in a report on Wednesday, October 30th. Oppenheimer reaffirmed an "outperform" rating and issued a $130.00 target price (down previously from $155.00) on shares of Transcat in a research report on Wednesday, October 30th. Finally, StockNews.com downgraded Transcat from a "hold" rating to a "sell" rating in a research note on Tuesday, October 29th.

Transcat Stock Up 2.1 %

TRNS traded up $2.19 during trading on Friday, hitting $108.26. The company had a trading volume of 47,205 shares, compared to its average volume of 56,153. The firm's 50-day moving average price is $105.72 and its 200 day moving average price is $117.44. The company has a market capitalization of $995.88 million, a PE ratio of 54.68 and a beta of 0.70. Transcat has a one year low of $94.29 and a one year high of $147.12.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.12). The firm had revenue of $67.83 million for the quarter, compared to analyst estimates of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. The firm's quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.41 earnings per share. Sell-side analysts forecast that Transcat will post 1.76 earnings per share for the current year.

Institutional Trading of Transcat

Hedge funds have recently made changes to their positions in the business. DekaBank Deutsche Girozentrale acquired a new stake in shares of Transcat during the 2nd quarter worth about $40,000. nVerses Capital LLC acquired a new stake in Transcat during the third quarter worth approximately $60,000. Quest Partners LLC bought a new stake in shares of Transcat during the second quarter worth approximately $109,000. US Bancorp DE increased its stake in shares of Transcat by 15.6% during the third quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company's stock worth $187,000 after purchasing an additional 209 shares during the period. Finally, Captrust Financial Advisors acquired a new stake in Transcat during the 3rd quarter worth approximately $201,000. 98.34% of the stock is owned by institutional investors and hedge funds.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.